ChromaDex launches the Niagen+ NAD+ Test Kit , now available exclusively through the company’s healthcare practitioner HCP channel. This innovative test kit provides practitioners with a reliable method for measuring patient blood NAD+ levels, helping them create more personalized and effective patient protocols using ChromaDex’s NAD+-boosting HCP products, Tru Niagen and Niagen+. Tru Niagen is a suite of oral dietary supplements featuring Niagen (patented nicotinamide riboside or NR, the most efficient and high-quality NAD+ precursor available. Niagen+ features pharmaceutical-grade Niagen, patented nicotinamide riboside chloride or NRC, and will soon be available as Niagen IV and injections exclusively at clinics from U.S. FDA 503B-registered outsourcing facilities with a prescription. Representing a significant advancement in intravenous NAD+ therapy, practitioners are eager to provide Niagen IV therapy to patients.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDXC:
- ChromaDex to debut pharmaceutical-grade Niagen at clinics in August
- ChromaDex to be included in Russell 2000 Index
- ChromaDex CFO Brianna Gerber Announces Resignation
- ChromaDex announces results from phase II study of NR supplementation
- ChromaDex receives orphan drug designation for Ataxia Telangiectasia cadidate
Questions or Comments about the article? Write to editor@tipranks.com